Accéder au contenu
Merck

Plasma protein changes in rats treated with hypolipidaemic drugs and with phthalate esters.

Human toxicology (1985-05-01)
R H Hinton, S C Price, F E Mitchell, A Mann, D E Hall, J W Bridges
RÉSUMÉ

Treatment of rats with hypolipidaemic drugs or with the plasticizer di-2-ethyl hexyl phthalate caused significant alterations in the concentration of certain plasma proteins. Certain proteins showed dose-dependent increases, in other cases the plasma concentrations fell in treated animals. The changes were quite distinct from the changes in plasma proteins which occur during the acute-phase response to inflammatory agents. Some changes appeared specific to agents which produce peroxisome proliferation in liver, other alterations appeared associated with mild, but sustained, liver injury.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Dioctyl phthalate, ≥98.0% (GC)
Supelco
Dioctyl phthalate, analytical standard
Supelco
Dioctyl phthalate, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland